Clinical utility of technetium-99m methoxisobutylisonitrile imaging in differentiated thyroid carcinoma: comparison with thallium-201 and iodine-131 Na scintigraphy, and serum thyroglobulin quantitation
- 1 November 1995
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 22 (11) , 1330-1338
- https://doi.org/10.1007/bf00801623
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Role of technetium-99m sestamibi in localisation of thyroid cancer metastases.1993
- The role of iodine-131 and thallium-201 imaging and serum thyroglobulin in the management of differentiated thyroid carcinomaCancer, 1993
- Differentiation of single solid lesions in the lungs by means of single-photon emission tomography with technetium-99m methoxyisobutylisonitrileEuropean Journal of Nuclear Medicine and Molecular Imaging, 1993
- Clinical Experience with Tc-99m MIBI Imaging in Patients with Malignant Tumors Preliminary Results and Comparison with TI-201Clinical Nuclear Medicine, 1992
- Visualization of Suppressed Thyroid Tissue by Tc-99m MIBIClinical Nuclear Medicine, 1991
- Biodistribution of Tc-99m methoxy-isobutyl-isonitrile (MIBI) in humansEuropean Journal of Nuclear Medicine and Molecular Imaging, 1989
- Uptake and Kinetics of Tc-99m Hexakis 2-Methoxy Isobutyl Isonitrile in Benign and Malignant Lesions in the LungsClinical Nuclear Medicine, 1989
- Accumulation of lodine-131 and Technetium-99m Pertechnetate in Thyroid CarcinomaClinical Nuclear Medicine, 1988
- ROLE OF TL-201 TOTAL-BODY SCINTIGRAPHY IN FOLLOW-UP OF THYROID-CARCINOMA1986
- Diffuse Uptake of Technetium-99m Pertechnetate in a Patient with Metastases from Thyroid CarcinomaClinical Nuclear Medicine, 1986